QureGenAI

QureGen is a biotechnology company specializing in the application of generative artificial intelligence to RNA-targeted drug discovery. The company utilizes proprietary foundation models to decode complex RNA structures and RNA-protein interactions, enabling the design of highly specific small molecules and other therapeutic modalities. By integrating computational predictions with high-throughput experimental validation, QureGen aims to accelerate the development of treatments for challenging diseases, including oncology and rare genetic disorders. Their platform is designed to identify novel druggable sites on RNA molecules that were previously considered 'undruggable.' Headquartered in Houston, Texas, QureGen is positioned at the intersection of deep learning and molecular biology to transform the therapeutic landscape.